查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2030 年全身麻醉市场预测：按药物类型、给药途径、应用、最终用户和地区进行的全球分析
市场调查报告书
商品编码
1383361

2030 年全身麻醉市场预测：按药物类型、给药途径、应用、最终用户和地区进行的全球分析

General Anesthesia Market Forecasts to 2030 - Global Analysis By Type of Drugs (Propofol, Desflurane, Sevoflurane, Thiopental and Other Type of Drugs), Route of Administration (Inhalation and Intravenous), Application, End User and By Geography.
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球全身麻醉市场规模为 60.1 亿美元，预计 2030 年将达到 87.4 亿美元，预测期内年复合成长率为 6.2%。

全身麻醉是一种在医疗程序或手术期间诱导患者进入意识状态、镇痛、肌肉放鬆和失忆的医疗状况。全身麻醉可以延长手术时间，有利于儿童和老年患者，并有利于严重治疗和诊断测试。

根据互动式心血管和胸腔外科的数据，到 2022 年 4 月，大约有 227,442 名 70 岁以上的人将接受心血管手术。

手术次数增加

外科手术的增加是全身麻醉市场的关键驱动因素。随着世界人口的增长和高龄化，对手术介入的需求不断增加，以解决各种医疗状况，从常规手术到复杂的救命手术。全身麻醉对于确保患者在这些手术期间的舒适和安全至关重要，因为它会引起受控的意识丧失和镇痛状态。此外，新兴国家手术技术的进步和医疗基础设施的扩张也促进了手术数量的增加。对全身麻醉服务和产品的需求不断增长预计将继续推动医疗保健行业的市场成长。

设备和药品费用

麻醉需要专门的设备和药物，这两者都可能非常昂贵。麻醉仪器、监视器和药物的初始资本投资较高，可能会导致医疗机构的财务资源紧张。此外，还存在与维护、药品供应和符合安全标准的更新相关的持续成本。这种财务负担可能会限制麻醉服务的获得，特别是在资源有限的医疗机构中，并可能抑制某些机构提供或扩大麻醉服务，使全身麻醉更加昂贵，并可能限制市场成长。

微创手术需求

微创手术（MIS）对于全身麻醉市场来说是一个巨大的机会。这种手术方法包括腹腔镜检查和内视镜等手术，依靠麻醉来确保患者在手术过程中舒适和不动。这种手术因其切口较小、术后疼痛较少、住院时间较短和恢復时间更快等优点而越来越受欢迎。随着微创手术的需求不断增加，对适当麻醉服务和产品的需求也增加。在这些微创手术过程中，麻醉在维持病人安全和舒适方面发挥着至关重要的作用，使其成为医疗保健系统不可或缺的一部分，以适应这一不断增长的趋势。这一趋势预计将推动全身麻醉市场的成长。

安全问题

安全问题是全身麻醉市场的主要威胁。麻醉对于手术期间患者的舒适度至关重要，但也存在固有的风险，包括过敏反应、不利事件和罕见的併发症。与麻醉相关的引人注目的事件可能会削弱公众的信任并引起患者的担忧。安全仍然是医疗保健提供者的首要任务，任何感知到的风险都可能阻止患者选择手术或麻醉。此外，严格的安全标准和法规要求可能会增加提供麻醉服务的复杂性和成本。

COVID-19 的影响

COVID-19的疫情对全身麻醉市场产生了重大影响。第一波 COVID-19 导致择期手术延后，以节省资源、优先考虑 COVID-19 患者并降低感染风险。手术量的大幅下降对全身麻醉服务的需求产生了重大影响，影响了麻醉提供者和整个医疗保健行业。此外，供应链中断导致基本麻醉剂和设备的短缺和价格上涨。儘管存在这些挑战，大流行促使麻醉护理中迅速普及远端医疗和远端监控，以尽量减少面对面的接触。儘管疫情造成了暂时中断的局面，但医疗保健领域对麻醉服务的需求仍然至关重要，预计市场将在疫情后的情况下恢復和适应。

静脉注射预计将成为预测期内最大的细分市场

静脉注射部分估计占最大份额。全身麻醉市场的静脉部分是指透过静脉将麻醉剂直接给药病人的血液中。此方法可确保麻醉快速起效并可精确控制麻醉效果。静脉麻醉常用于各种外科手术和医疗干预，包括全身麻醉的诱导和维持。此外，麻醉师和医疗保健专业人员在整个手术过程中仔细监测和调整药物给药，以维持患者的意识、镇痛和生理稳定性。静脉麻醉是全身麻醉的基本且多功能的组成部分，有助于提高患者的舒适度、安全性以及手术和医疗干预的成功。

普通外科在预测期内的年复合成长率最高。

预计普外科领域在预测期内将出现良好的成长。一般外科包括广泛的外科手术，不属于心血管手术或神经外科等专门类别。这些手术通常给药全身麻醉，以确保患者舒适、肌肉放鬆和失去意识。这使得外科医生能够精确地进行各种手术，包括阑尾切除术、疝气修復和胆囊切除术。此外，一般外科对全身麻醉的需求很高，因为它能够控制疼痛、固定和受控的手术环境，从而在各种外科手术的成功中发挥着重要作用，并对全身麻醉市场做出了重大贡献。

比最大的地区

在预测期内，亚太地区占据了最大的市场占有率。推动亚太地区扩张的因素包括人口快速成长、医疗保健基础设施的改善以及外科手术机会的增加。该地区的高龄化正在推动外科手术的需求，特别是在中国和印度等国家。此外，先进医疗技术的采用和对病人安全意识的提高也有助于麻醉市场的成长。此外，政府在医疗保健领域的配合措施和外国投资预计将进一步加强亚太地区全身麻醉市场，并成为全球医疗保健格局的关键贡献者。

复合年复合成长率最高的地区：

预计北美在预测期内将实现盈利成长。该地区的特点是医疗基础设施先进、医疗成本高以及对病人安全的重视。技术进步、严格的法规标准以及对患者舒适度和安全性的关注正在推动该市场的持续成长。此外，该地区在麻醉技术、设备和药品方面拥有重要的研究和创新。该地区的全身麻醉市场对医疗保健仍然至关重要，因为北美医疗保健系统在 COVID-19大流行后重新强调安全性，以适应新的挑战。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球全身麻醉市场：依药物类型

  • 异丙酚
  • 地氟烷
  • 七氟醚
  • 蒂彭塔尔
  • 其他类型的药物

第6章全球全身麻醉市场：依给药途径

  • 吸入
  • 静脉

第7章全球全身麻醉市场：依应用分类

  • 心血管外科
  • 神经外科
  • 整形外科
  • 一般外科
  • 胃肠道治疗
  • 其他用途

第8章全球全身麻醉市场：依最终使用者分类

  • 医院
  • 门诊手术中心
  • 专科诊所

第9章全球全身麻醉市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第11章公司简介

  • Baxter International Inc.
  • Pfizer Inc.
  • Fresenius SE & Co. KGaA
  • Abbott Laboratories
  • Medtronic plc
  • AbbVie Inc.
  • Johnson & Johnson
  • Merck & Co., Inc.
  • GE Healthcare
  • AstraZeneca plc
  • Avet Pharmaceuticals Inc
  • Paion AG
  • Hikma Pharmaceuticals plc
  • Aspen Pharmacare Holdings Limited
  • Claris Lifesciences Limited
  • Glenmark Pharmaceuticals Limited
  • F. Hoffmann-La Roche Ltd
  • Maruishi Pharmaceutical Co. Ltd.
  • Pacira Pharmaceuticals Inc.
  • Teva Pharmaceutical Industries Limited
Product Code: SMRC24211

According to Stratistics MRC, the Global General Anaesthesia Market is accounted for $6.01 billion in 2023 and is expected to reach $8.74 billion by 2030 growing at a CAGR of 6.2% during the forecast period. General anaesthesia is a medical state induced in a patient to ensure unconsciousness, analgesia, muscle relaxation, and amnesia during a medical procedure or surgery. It allows for extended surgeries, benefits paediatric and geriatric patients, and facilitates critical care and diagnostic tests.

According to the Interactive cardiovascular and thoracic surgery, in April 2022, it was reported that around 227,442 populations above 70 years undergo cardiovascular procedure.

Market Dynamics:

Driver:

Increasing surgical procedures

The increasing number of surgical procedures is a significant driver of the general anaesthesia market. As the global population grows and ages, there is a rising demand for surgical interventions to address various medical conditions, from routine surgeries to complex, life-saving procedures. General anaesthesia is essential in ensuring patient comfort and safety during these surgeries, as it induces a controlled state of unconsciousness and analgesia. Furthermore, advancements in surgical techniques and the expansion of healthcare infrastructure in developing countries contribute to the growing number of surgeries. This increased demand for general anaesthesia services and products is expected to continue driving market growth in the healthcare industry.

Restraint:

Cost of equipment and drugs

Anaesthesia requires specialised equipment and pharmaceuticals, both of which come at a considerable expense. High initial capital investments for anaesthesia machines, monitors, and medication procurement can strain the financial resources of healthcare facilities. Moreover, the ongoing costs of maintenance, drug supplies, and updates to comply with safety standards can be burdensome. This financial burden can limit the accessibility of anaesthesia services, particularly in resource-constrained healthcare settings, and may discourage some facilities from offering or expanding these services, thus restraining the growth of the general anaesthesia market.

Opportunity:

Demand for minimally invasive surgery

Minimally Invasive Surgery (MIS) represents a significant opportunity for the general anaesthesia market. This surgical approach, which includes procedures like laparoscopy and endoscopy, relies on anaesthesia to ensure patient comfort and immobility during surgery. This surgery is gaining popularity due to its benefits, including smaller incisions, reduced postoperative pain, shorter hospital stays, and quicker recovery times. As the demand for minimally invasive surgery procedures continues to rise, the need for appropriate anaesthesia services and products increases. Anaesthesia plays a crucial role in maintaining patient safety and comfort during these minimally invasive surgeries, making it an integral part of the healthcare system's response to this growing trend. This trend is expected to drive the growth of the general anaesthesia market.

Threat:

Safety concerns

Safety concerns represent a significant threat to the general anaesthesia market. Anaesthesia, while crucial for patient comfort during surgery, carries inherent risks, including allergic reactions, adverse events, and rare complications. High-profile cases of anaesthesia-related incidents can erode public trust and raise concerns among patients. Safety remains a paramount focus for healthcare providers, and any perceived risk can deter patients from opting for surgery or anaesthesia. Additionally, stringent safety standards and regulatory requirements can increase the complexity and cost of providing anaesthesia services.

COVID-19 Impact

The COVID-19 pandemic has exerted a significant impact on the general anaesthesia market. The initial wave of COVID-19 led to the postponement of elective surgeries to conserve resources, prioritise COVID-19 patients, and reduce infection risk. This substantial reduction in surgical volume significantly affected the demand for general anaesthesia services, impacting both anaesthesia providers and the broader healthcare industry. Additionally, supply chain disruptions led to shortages and increased prices for essential anaesthesia drugs and equipment. Despite these challenges, the pandemic prompted the rapid adoption of telemedicine and remote monitoring in anaesthesia care to minimise in-person contact. While the pandemic had a temporary disruptive effect, the need for anaesthesia services remains essential in healthcare, and the market is expected to recover and adapt in the post-pandemic landscape.

The Intravenous segment is expected to be the largest during the forecast period

The Intravenous segment is estimated to hold the largest share. The intravenous segment of the general anaesthesia market refers to the administration of anaesthesia drugs directly into the patient's bloodstream via a vein. This method ensures the rapid onset of anaesthesia, allowing for precise control of the anaesthetic effect. IV anaesthesia is commonly used in various surgical procedures and medical interventions, including the induction and maintenance of general anaesthesia. Furthermore, anaesthesiologists and healthcare providers carefully monitor and adjust the drug dosage throughout the procedure to maintain the patient's unconsciousness, analgesia, and physiological stability. IV anaesthesia is a fundamental and versatile component of general anaesthesia, contributing to patient comfort, safety, and the success of surgical and medical interventions.

The General Surgery segment is expected to have the highest CAGR during the forecast period

The General Surgery segment is anticipated to have lucrative growth during the forecast period. General surgery encompasses a wide range of surgical procedures that don't fall under specialised categories like cardiac or neurological surgeries. General anaesthesia is commonly administered in these surgeries to ensure patient comfort, muscle relaxation, and unconsciousness. It enables surgeons to perform various procedures, such as appendectomy, hernia repairs, gallbladder removal, and many more, with precision. Furthermore, the demand for general anaesthesia in general surgery is significant, as it allows for pain control, immobility, and a controlled surgical environment, playing a vital role in the success of diverse surgical interventions and contributing significantly to the general anaesthesia market.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period. Factors driving its expansion include a burgeoning population, rising healthcare infrastructure, and increasing access to surgical interventions. The region's ageing population has led to a higher demand for surgical procedures, particularly in countries like China and India. Furthermore, the adoption of advanced healthcare technologies and the increasing awareness of patient safety contribute to the growth of the anaesthesia market. Moreover, government initiatives and foreign investments in healthcare are expected to further bolster the Asia-Pacific general anaesthesia market, making it a pivotal contributor to the global healthcare landscape.

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period. The region is characterised by advanced healthcare infrastructure, high healthcare expenditures, and a strong emphasis on patient safety. Technological advancements, stringent regulatory standards, and a focus on patient comfort and safety drive continuous growth in this market. Additionally, the region is marked by significant research and innovation in anaesthesia techniques, equipment, and pharmaceuticals. The COVID-19 pandemic prompted a renewed emphasis on safety, and North America's healthcare systems have adapted to new challenges, ensuring that the general anaesthesia market in this region remains pivotal in the field of healthcare.

Key players in the market

Some of the key players in the General Anesthesia Market include: Baxter International Inc., Pfizer Inc., Fresenius SE & Co. KGaA, Abbott Laboratories, Medtronic plc, AbbVie Inc., Johnson & Johnson, Merck & Co., Inc., GE Healthcare, AstraZeneca plc, Avet Pharmaceuticals Inc, Paion AG, Hikma Pharmaceuticals plc, Aspen Pharmacare Holdings Limited, Claris Lifesciences Limited, Glenmark Pharmaceuticals Limited, F. Hoffmann-La Roche Ltd, Maruishi Pharmaceutical Co. Ltd., Pacira Pharmaceuticals Inc. and Teva Pharmaceutical Industries Limited.

Key Developments:

In April 2022, GE Healthcare, a U.S.-based multinational healthcare and medical technology company, received the U.S. Food and Drugs Approval (FDA) pre-market approval (PMA) for its End-tidal (Et) control software for general anesthesia delivery on its Aisys CS2 Anesthesia Delivery System. The device is to have a direct control of the end-tidal concentration that reflects the drug level in the patient's blood along with that low-flow anesthesia has benefits for hospitals and the environment.

In February 2022, Sedana Medical AB has launched Sedaconda (isoflurane) in Germany. Sedaconda (isoflurane) will be approved by the European DCP In addition, in July 2021. the product has been granted national approval in 14 nations. Additional marketing clearance applications were submitted in the same year, and the business expects to gain national approvals in Italy, Poland, Switzerland, and the United Kingdom in 2022.

In January 2022, Akorn Operating Company LLC has agreed to sell seven branded ophthalmic products to Laboratoires Thea SAS (Thea). Thea will be able to add Akorn-branded medicines to its portfolio, including Akten (lidocaine HCl ophthalmic gel), a local anaesthetic intended for ocular surface anaesthetic during ophthalmologic operations, as a result of the strategic move.

Type of Drugs Covered:

  • Propofol
  • Desflurane
  • Sevoflurane
  • Thiopental
  • Other Type of Drugs

Route of Administrations Covered:

  • Inhalation
  • Intravenous

Applications Covered:

  • Cardiovascular Surgeries
  • Neurosurgeries
  • Orthopedic Surgeries
  • General Surgery
  • Gastrointestinal Procedures
  • Other Applications

End Users Covered:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global General Anesthesia Market, By Type of Drugs

  • 5.1 Introduction
  • 5.2 Propofol
  • 5.3 Desflurane
  • 5.4 Sevoflurane
  • 5.5 Thiopental
  • 5.6 Other Type of Drugs

6 Global General Anesthesia Market, By Route of Administration

  • 6.1 Introduction
  • 6.2 Inhalation
  • 6.3 Intravenous

7 Global General Anesthesia Market, By Application

  • 7.1 Introduction
  • 7.2 Cardiovascular Surgeries
  • 7.3 Neurosurgeries
  • 7.4 Orthopedic Surgeries
  • 7.5 General Surgery
  • 7.6 Gastrointestinal Procedures
  • 7.7 Other Applications

8 Global General Anesthesia Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Ambulatory Surgical Centers
  • 8.4 Specialty Clinics

9 Global General Anesthesia Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Baxter International Inc.
  • 11.2 Pfizer Inc.
  • 11.3 Fresenius SE & Co. KGaA
  • 11.4 Abbott Laboratories
  • 11.5 Medtronic plc
  • 11.6 AbbVie Inc.
  • 11.7 Johnson & Johnson
  • 11.8 Merck & Co., Inc.
  • 11.9 GE Healthcare
  • 11.10 AstraZeneca plc
  • 11.11 Avet Pharmaceuticals Inc
  • 11.12 Paion AG
  • 11.13 Hikma Pharmaceuticals plc
  • 11.14 Aspen Pharmacare Holdings Limited
  • 11.15 Claris Lifesciences Limited
  • 11.16 Glenmark Pharmaceuticals Limited
  • 11.17 F. Hoffmann-La Roche Ltd
  • 11.18 Maruishi Pharmaceutical Co. Ltd.
  • 11.19 Pacira Pharmaceuticals Inc.
  • 11.20 Teva Pharmaceutical Industries Limited

List of Tables

  • Table 1 Global General Anesthesia Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global General Anesthesia Market Outlook, By Type of Drugs (2021-2030) ($MN)
  • Table 3 Global General Anesthesia Market Outlook, By Propofol (2021-2030) ($MN)
  • Table 4 Global General Anesthesia Market Outlook, By Desflurane (2021-2030) ($MN)
  • Table 5 Global General Anesthesia Market Outlook, By Sevoflurane (2021-2030) ($MN)
  • Table 6 Global General Anesthesia Market Outlook, By Thiopental (2021-2030) ($MN)
  • Table 7 Global General Anesthesia Market Outlook, By Other Type of Drugs (2021-2030) ($MN)
  • Table 8 Global General Anesthesia Market Outlook, By Route of Administration (2021-2030) ($MN)
  • Table 9 Global General Anesthesia Market Outlook, By Inhalation (2021-2030) ($MN)
  • Table 10 Global General Anesthesia Market Outlook, By Intravenous (2021-2030) ($MN)
  • Table 11 Global General Anesthesia Market Outlook, By Application (2021-2030) ($MN)
  • Table 12 Global General Anesthesia Market Outlook, By Cardiovascular Surgeries (2021-2030) ($MN)
  • Table 13 Global General Anesthesia Market Outlook, By Neurosurgeries (2021-2030) ($MN)
  • Table 14 Global General Anesthesia Market Outlook, By Orthopedic Surgeries (2021-2030) ($MN)
  • Table 15 Global General Anesthesia Market Outlook, By General Surgery (2021-2030) ($MN)
  • Table 16 Global General Anesthesia Market Outlook, By Gastrointestinal Procedures (2021-2030) ($MN)
  • Table 17 Global General Anesthesia Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 18 Global General Anesthesia Market Outlook, By End User (2021-2030) ($MN)
  • Table 19 Global General Anesthesia Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 20 Global General Anesthesia Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 21 Global General Anesthesia Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 22 North America General Anesthesia Market Outlook, By Country (2021-2030) ($MN)
  • Table 23 North America General Anesthesia Market Outlook, By Type of Drugs (2021-2030) ($MN)
  • Table 24 North America General Anesthesia Market Outlook, By Propofol (2021-2030) ($MN)
  • Table 25 North America General Anesthesia Market Outlook, By Desflurane (2021-2030) ($MN)
  • Table 26 North America General Anesthesia Market Outlook, By Sevoflurane (2021-2030) ($MN)
  • Table 27 North America General Anesthesia Market Outlook, By Thiopental (2021-2030) ($MN)
  • Table 28 North America General Anesthesia Market Outlook, By Other Type of Drugs (2021-2030) ($MN)
  • Table 29 North America General Anesthesia Market Outlook, By Route of Administration (2021-2030) ($MN)
  • Table 30 North America General Anesthesia Market Outlook, By Inhalation (2021-2030) ($MN)
  • Table 31 North America General Anesthesia Market Outlook, By Intravenous (2021-2030) ($MN)
  • Table 32 North America General Anesthesia Market Outlook, By Application (2021-2030) ($MN)
  • Table 33 North America General Anesthesia Market Outlook, By Cardiovascular Surgeries (2021-2030) ($MN)
  • Table 34 North America General Anesthesia Market Outlook, By Neurosurgeries (2021-2030) ($MN)
  • Table 35 North America General Anesthesia Market Outlook, By Orthopedic Surgeries (2021-2030) ($MN)
  • Table 36 North America General Anesthesia Market Outlook, By General Surgery (2021-2030) ($MN)
  • Table 37 North America General Anesthesia Market Outlook, By Gastrointestinal Procedures (2021-2030) ($MN)
  • Table 38 North America General Anesthesia Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 39 North America General Anesthesia Market Outlook, By End User (2021-2030) ($MN)
  • Table 40 North America General Anesthesia Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 41 North America General Anesthesia Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 42 North America General Anesthesia Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 43 Europe General Anesthesia Market Outlook, By Country (2021-2030) ($MN)
  • Table 44 Europe General Anesthesia Market Outlook, By Type of Drugs (2021-2030) ($MN)
  • Table 45 Europe General Anesthesia Market Outlook, By Propofol (2021-2030) ($MN)
  • Table 46 Europe General Anesthesia Market Outlook, By Desflurane (2021-2030) ($MN)
  • Table 47 Europe General Anesthesia Market Outlook, By Sevoflurane (2021-2030) ($MN)
  • Table 48 Europe General Anesthesia Market Outlook, By Thiopental (2021-2030) ($MN)
  • Table 49 Europe General Anesthesia Market Outlook, By Other Type of Drugs (2021-2030) ($MN)
  • Table 50 Europe General Anesthesia Market Outlook, By Route of Administration (2021-2030) ($MN)
  • Table 51 Europe General Anesthesia Market Outlook, By Inhalation (2021-2030) ($MN)
  • Table 52 Europe General Anesthesia Market Outlook, By Intravenous (2021-2030) ($MN)
  • Table 53 Europe General Anesthesia Market Outlook, By Application (2021-2030) ($MN)
  • Table 54 Europe General Anesthesia Market Outlook, By Cardiovascular Surgeries (2021-2030) ($MN)
  • Table 55 Europe General Anesthesia Market Outlook, By Neurosurgeries (2021-2030) ($MN)
  • Table 56 Europe General Anesthesia Market Outlook, By Orthopedic Surgeries (2021-2030) ($MN)
  • Table 57 Europe General Anesthesia Market Outlook, By General Surgery (2021-2030) ($MN)
  • Table 58 Europe General Anesthesia Market Outlook, By Gastrointestinal Procedures (2021-2030) ($MN)
  • Table 59 Europe General Anesthesia Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 60 Europe General Anesthesia Market Outlook, By End User (2021-2030) ($MN)
  • Table 61 Europe General Anesthesia Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 62 Europe General Anesthesia Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 63 Europe General Anesthesia Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 64 Asia Pacific General Anesthesia Market Outlook, By Country (2021-2030) ($MN)
  • Table 65 Asia Pacific General Anesthesia Market Outlook, By Type of Drugs (2021-2030) ($MN)
  • Table 66 Asia Pacific General Anesthesia Market Outlook, By Propofol (2021-2030) ($MN)
  • Table 67 Asia Pacific General Anesthesia Market Outlook, By Desflurane (2021-2030) ($MN)
  • Table 68 Asia Pacific General Anesthesia Market Outlook, By Sevoflurane (2021-2030) ($MN)
  • Table 69 Asia Pacific General Anesthesia Market Outlook, By Thiopental (2021-2030) ($MN)
  • Table 70 Asia Pacific General Anesthesia Market Outlook, By Other Type of Drugs (2021-2030) ($MN)
  • Table 71 Asia Pacific General Anesthesia Market Outlook, By Route of Administration (2021-2030) ($MN)
  • Table 72 Asia Pacific General Anesthesia Market Outlook, By Inhalation (2021-2030) ($MN)
  • Table 73 Asia Pacific General Anesthesia Market Outlook, By Intravenous (2021-2030) ($MN)
  • Table 74 Asia Pacific General Anesthesia Market Outlook, By Application (2021-2030) ($MN)
  • Table 75 Asia Pacific General Anesthesia Market Outlook, By Cardiovascular Surgeries (2021-2030) ($MN)
  • Table 76 Asia Pacific General Anesthesia Market Outlook, By Neurosurgeries (2021-2030) ($MN)
  • Table 77 Asia Pacific General Anesthesia Market Outlook, By Orthopedic Surgeries (2021-2030) ($MN)
  • Table 78 Asia Pacific General Anesthesia Market Outlook, By General Surgery (2021-2030) ($MN)
  • Table 79 Asia Pacific General Anesthesia Market Outlook, By Gastrointestinal Procedures (2021-2030) ($MN)
  • Table 80 Asia Pacific General Anesthesia Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 81 Asia Pacific General Anesthesia Market Outlook, By End User (2021-2030) ($MN)
  • Table 82 Asia Pacific General Anesthesia Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 83 Asia Pacific General Anesthesia Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 84 Asia Pacific General Anesthesia Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 85 South America General Anesthesia Market Outlook, By Country (2021-2030) ($MN)
  • Table 86 South America General Anesthesia Market Outlook, By Type of Drugs (2021-2030) ($MN)
  • Table 87 South America General Anesthesia Market Outlook, By Propofol (2021-2030) ($MN)
  • Table 88 South America General Anesthesia Market Outlook, By Desflurane (2021-2030) ($MN)
  • Table 89 South America General Anesthesia Market Outlook, By Sevoflurane (2021-2030) ($MN)
  • Table 90 South America General Anesthesia Market Outlook, By Thiopental (2021-2030) ($MN)
  • Table 91 South America General Anesthesia Market Outlook, By Other Type of Drugs (2021-2030) ($MN)
  • Table 92 South America General Anesthesia Market Outlook, By Route of Administration (2021-2030) ($MN)
  • Table 93 South America General Anesthesia Market Outlook, By Inhalation (2021-2030) ($MN)
  • Table 94 South America General Anesthesia Market Outlook, By Intravenous (2021-2030) ($MN)
  • Table 95 South America General Anesthesia Market Outlook, By Application (2021-2030) ($MN)
  • Table 96 South America General Anesthesia Market Outlook, By Cardiovascular Surgeries (2021-2030) ($MN)
  • Table 97 South America General Anesthesia Market Outlook, By Neurosurgeries (2021-2030) ($MN)
  • Table 98 South America General Anesthesia Market Outlook, By Orthopedic Surgeries (2021-2030) ($MN)
  • Table 99 South America General Anesthesia Market Outlook, By General Surgery (2021-2030) ($MN)
  • Table 100 South America General Anesthesia Market Outlook, By Gastrointestinal Procedures (2021-2030) ($MN)
  • Table 101 South America General Anesthesia Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 102 South America General Anesthesia Market Outlook, By End User (2021-2030) ($MN)
  • Table 103 South America General Anesthesia Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 104 South America General Anesthesia Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 105 South America General Anesthesia Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 106 Middle East & Africa General Anesthesia Market Outlook, By Country (2021-2030) ($MN)
  • Table 107 Middle East & Africa General Anesthesia Market Outlook, By Type of Drugs (2021-2030) ($MN)
  • Table 108 Middle East & Africa General Anesthesia Market Outlook, By Propofol (2021-2030) ($MN)
  • Table 109 Middle East & Africa General Anesthesia Market Outlook, By Desflurane (2021-2030) ($MN)
  • Table 110 Middle East & Africa General Anesthesia Market Outlook, By Sevoflurane (2021-2030) ($MN)
  • Table 111 Middle East & Africa General Anesthesia Market Outlook, By Thiopental (2021-2030) ($MN)
  • Table 112 Middle East & Africa General Anesthesia Market Outlook, By Other Type of Drugs (2021-2030) ($MN)
  • Table 113 Middle East & Africa General Anesthesia Market Outlook, By Route of Administration (2021-2030) ($MN)
  • Table 114 Middle East & Africa General Anesthesia Market Outlook, By Inhalation (2021-2030) ($MN)
  • Table 115 Middle East & Africa General Anesthesia Market Outlook, By Intravenous (2021-2030) ($MN)
  • Table 116 Middle East & Africa General Anesthesia Market Outlook, By Application (2021-2030) ($MN)
  • Table 117 Middle East & Africa General Anesthesia Market Outlook, By Cardiovascular Surgeries (2021-2030) ($MN)
  • Table 118 Middle East & Africa General Anesthesia Market Outlook, By Neurosurgeries (2021-2030) ($MN)
  • Table 119 Middle East & Africa General Anesthesia Market Outlook, By Orthopedic Surgeries (2021-2030) ($MN)
  • Table 120 Middle East & Africa General Anesthesia Market Outlook, By General Surgery (2021-2030) ($MN)
  • Table 121 Middle East & Africa General Anesthesia Market Outlook, By Gastrointestinal Procedures (2021-2030) ($MN)
  • Table 122 Middle East & Africa General Anesthesia Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 123 Middle East & Africa General Anesthesia Market Outlook, By End User (2021-2030) ($MN)
  • Table 124 Middle East & Africa General Anesthesia Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 125 Middle East & Africa General Anesthesia Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 126 Middle East & Africa General Anesthesia Market Outlook, By Specialty Clinics (2021-2030) ($MN)